The curative effect analysis of Shenmai injection in the treatment of patients with septic shock and its effect on cellular immune function
Wenming Zhang
Abstract
Wenming Zhang
Abstract
Objective To investigate the clinical efficacy of Shenmai injection in the treatment of patients with septic shock and its effect on cellular immune function. Methods 82 cases of patients with septic shock were randomly divided into experimental group (n=41) and control group (n=41). The control group was given western medical therapy, and the experimental group was treated with Shenmai injection on the basis of the treatment in the control group. Both groups were treated for 7 d. Made a comparison of clinical efficacy, changes of blood lactate, proealcitonin(PCT), and cellar immune function before and 7 d after treatment in both groups. Results The improvement rate in the experimental group was significantly higher than that in the control group (70.73% vs.46.34%), with statistically significant difference (P 0.05); compared with before treatment, the levels of CD3+, CD4+, CD4+/CD8+ in the experimental group after treatment significantly increased, with statistically significant differences (P<0.05); the levels of CD3+, CD4+, CD4+/CD8+ after treatment in the experimental group were significantly higher than those in the control group, with statistically significant differences (P<0.05). Conclusion Shenmai injection in the treatment of patients with septic shock has striking clinical effect, which can improve cellular immune function of patients obviously. Key words: Septic shock; Shenmai injection; Clinical efficacy; Cellular immune function
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical efficacy of Shenmai injection in the treatment of patients with septic shock and its effect on cellular immune function. Methods 82 cases of patients with septic shock were randomly divided into experimental group (n=41) and control group (n=41). The control group was given western medical therapy, and the experimental group was treated with Shenmai injection on the basis of the treatment in the control group. Both groups were treated for 7 d. Made a comparison of clinical efficacy, changes of blood lactate, proealcitonin(PCT), and cellar immune function before and 7 d after treatment in both groups. Results The improvement rate in the experimental group was significantly higher than that in the control group (70.73% vs.46.34%), with statistically significant difference (P 0.05); compared with before treatment, the levels of CD3+, CD4+, CD4+/CD8+ in the experimental group after treatment significantly increased, with statistically significant differences (P<0.05); the levels of CD3+, CD4+, CD4+/CD8+ after treatment in the experimental group were significantly higher than those in the control group, with statistically significant differences (P<0.05). Conclusion Shenmai injection in the treatment of patients with septic shock has striking clinical effect, which can improve cellular immune function of patients obviously. Key words: Septic shock; Shenmai injection; Clinical efficacy; Cellular immune function
Key concepts: Septic shock, Immune system, Medicine, CD8, Shock (circulatory), Internal medicine, Significant difference, Clinical efficacy